IP Library Granted Patent US 11,617,517
Granted Patent B2
US 11,617,517 · App. 15/088,988 · Granted Apr 4, 2023

System and method for non-invasive instantaneous and continuous measurement of cardiac chamber volume

Inventor: Joe P. Tupin, Jr. (Chantilly, VA)
Assignee: Lifewave Biomedical, Inc.
A61B5/05A61B5/026A61B5/029A61B5/02028A61B5/0507A61B5/411A61B5/6823A61B6/508A61B6/507
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,617,517
App. No.
15/088,988
Filed
Apr 1, 2016
Granted
Apr 4, 2023
Kind
B2
Art Unit
3793
USPC
600/424
Abstract

A system and method for non-invasive and continuous measurement of cardiac chamber volume and derivative parameters including stroke volume, cardiac output and ejection fraction comprising an ultrawideband radar system having a trans-mitting and receiving antenna for applying ultrawideband radio signals to a target area of a subject's anatomy wherein the receiving antenna collects and transmits signal returns from the target area which are then delivered to a data processing unit, such as an integrated processor or PDA, having software and hardware used to process the signal returns to produce a value for cardiac stroke volume and changes in cardiac stroke volume supporting multiple diagnostic requirements for emergency response and medical personnel whether located in the battlefield, at a disaster site or at a hospital or other treatment facility.

Claims (27)

1. A medical device for determining a change in the spatial configuration of a heart, comprising:

a low pulse repetition frequency transmitter including at least one antenna and generating a series of radiofrequency pulses;

a swept-range receiver, wherein the at least one antenna is adapted to be located adjacent a portion of the heart; and

a processor configured for determining heart wall excursions based on reflected signals and determining a cardiac chamber volume based on positions of the heart wall excursions and presumed dimensions of a heart chamber, wherein said processor of the medical device is configured for resolving a change in the reflected signals that is functionally related to a change in cardiac chamber volume, and wherein the swept-range receiver captures the reflected signals across a target range of interest, and further wherein the processor integrates a predetermined number of the reflected signals for at least one range of interest within the target range of interest, wherein said processor is configured to identify one or more signals that qualify for further analysis by capturing and prioritizing the one or more signals with respect to minimum discontinuities.

2. A medical device according to claim 1 wherein the device is adapted to be located external to the body.

3. A medical device, according to claim 1 , further comprising a substrate and further wherein the at least one antenna is coupled to said substrate in a pattern and configured for both transmitting and receiving radiofrequency signals.

4. A medical device according to claim 1 , wherein the reflected signals are derivative of an earlier transmitted ultrawideband signal having a frequency band extending up to 15 GHz, further wherein the at least one antenna is configured to transmit ultrawideband signals having a frequency band extending up to 15 GHz.

5. A medical device according to claim 1 , wherein the reflected signals are derivative of an earlier transmitted ultrawideband signal having a frequency band extending from 3.1 GHz to 10.6 GHz, further wherein the at least one antenna is configured to transmit ultrawideband signals having a frequency band extending from 3.1 GHz to 10.6 GHz.

6. A medical device according to claim 5 wherein the transmitted ultrawideband signal is compliant with applicable FCC regulations, further wherein the at least one antenna is configured to transmit ultrawideband signals.

7. A medical device according to claim 1 wherein the device is configured to collect data from the heart.

8. A medical device, according to claim 7 , wherein the medical device is configured to collect said data from a targeted portion of the heart.

9. A medical device according to claim 8 wherein said targeted portion is selected from a group consisting of the left ventricle, right ventricle, left atrium, right atrium, mitral valve, pulmonary valve, aortic valve, and tricuspid valve.

10. A medical device, comprising: a processor, and a radar transceiver having at least one antenna to be located adjacent a portion of a heart to measure dynamic motion of a targeted portion of the heart, wherein said processor further comprises software configured to cause said processor to be configured for resolving a change in a spatial configuration of the heart, wherein said processor controls said radar transceiver, and said radar transceiver transmits radiofrequency energy at said targeted portion of the heart and said radar transceiver receives reflections of said transmitted radiofrequency energy from said targeted portion of the heart and said at least one antenna couples the radiofrequency energy between said transceiver and said targeted portion of the heart, wherein the radar transceiver comprises a low pulse repetition frequency transmitter and a swept-range receiver, wherein the low pulse repetition frequency transmitter generates a series of radiofrequency pulses, and the swept-range receiver captures the reflections across a target range of interest, wherein the processor integrates a predetermined number of reflections for at least one range of interest within the target range of interest, wherein said processor is configured to identify one or more signals that qualify for further analysis by capturing and prioritizing the one or more signals with respect to minimum discontinuities.

11. A medical device according to claim 10 wherein said processor controls said transceiver to transmit radiofrequency energy at a target and receive reflections of radiofrequency energy from the target to create a coupling of energy between said transceiver and the target.

12. A medical device according to claim 10 wherein said change in spatial configuration is functionally related to a change in chamber volume, wherein the processor is adapted to determine the chamber volume using a volumetric model comprised of a volumetric voxel mesh composed of a set of small cubic cells.

13. A medical device, according to claim 10 , further comprising a substrate; said at least one antenna mounted to said substrate and being for sensing reflected signals; and a plurality of conductors extending from said at least one antenna and electrically coupled with said processor.

14. A medical device, according to claim 10 , further comprising a substrate, wherein the at least one antenna is coupled to said substrate in a pattern and configured for sensing reflected signals; and at least one conductor extending from said at least one antenna and electrically coupled with said processor.

15. A medical device, according to claim 10 , wherein said at least one antenna is adapted to be located on a subject's chest adjacent a portion of the heart.

16. A medical device, according to claim 10 , wherein said at least one antenna is adapted to be located within a five centimeter radius of a center point of the sternum so as to collect reflected signals caused by the beating of the heart.

17. The medical device, according to claim 10 , further wherein after a predetermined number of reflections for a first range of interest are collected and integrated, the software causes receiver sample timing to change, allowing capture of the reflections from a next range of interest.

18. A method of determining a change in the spatial configuration of a heart, comprising:

positioning a low pulse repetition frequency transmitter having at least one antenna adapted to be located adjacent a portion of the heart, the transmitter for transmitting a signal in the form of a series of radio frequency pulses and automatically and continually adjusting a direction of the transmitted signal as controlled by a processor;

receiving reflected signals using a swept-range receiver that captures the reflected signals across a target range of interest, wherein said processor is configured for resolving a change in reflected signals that are functionally related to a change in cardiac chamber volume;

integrating a sample of the reflected signals to minimize noise, wherein the processor collects and integrates a predetermined number of reflected signals for at least one range of interest within the target range of interest; and

identifying cardiac wall excursions based on the integrated sample of the reflected signals;

determining a cardiac chamber volume based on a position of the cardiac wall excursions and presumed dimensions of a heart chamber; and

identifying one or more signals that qualify for further analysis by capturing and prioritizing the one or more signals with respect to minimum discontinuities.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 1, 2018
From: TUPIN, JOE PAUL, JR.
To: LIFEWAVE BIOMEDICAL, INC.
Reel/Frame 047172/0390 →
Continuity (4)
Continuation 13902623 · May 24, 2013
Division 12601665
Provisional Application 60939855 · May 24, 2007
Related Publication 20170055872A1 · Mar 2, 2017
Cited By (1)
US 12,719,592